PIK3CA and cancer: An analogous observation was made by Kim et al. [17], which provided evidence that PIK3CA mutations were associated with a higher recurrence-free survival (HR: 0.35; p = 0.01) and better cancer-specific survival (HR: 0.35; p = 0.04) in patients treated with radical cystectomy.